About Surge Pharmaceuticals Private Limited
Data last updated:
Surge Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2007PTC051709. Its GSTIN is 10AALCS4016J1ZL (Bihar). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1.1 Cr and a paid-up capital of ₹65 Lakh. It is led by directors Satyendra Kumar and Bibhuti Kumar Verma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sb – 28/A Arpan Complex Nizampura, Vadodara, Gujarat, India – 390002.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.94 Cr. For the same year it recorded a net profit of ₹6.88 Lakh (net margin 0.3%) and EBITDA of ₹1.51 Cr (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 14% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Surge Pharmaceuticals. As per MCA filings, the company has open charges of ₹4.7 Cr and satisfied charges of ₹2.25 Cr on record. Court records list 17 cases involving the company, including 4 filed by the company and 13 filed against it; 5 cases are pending. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2020.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surgepharma.com.
Company details
Contact details
Surge Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is surgepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSb – 28/A Arpan Complex Nizampura, Vadodara, Gujarat, India – 390002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Surge Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Surge Pharmaceuticals operates one associated brand: Surge Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies affordable quality medicines worldwide through efficient facilities. | surgepharma.com |
Business activity
The main business activity of Surge Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Surge Pharmaceuticals Private Limited, buy the company report.
Financials of Surge Pharmaceuticals Private Limited
FY 2024 filings availableSurge Pharmaceuticals Private Limited reported revenue of ₹25.94 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹25.94 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.51 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surge Pharmaceuticals Private Limited, buy the company report.
Board of directors of Surge Pharmaceuticals Private Limited
Surge Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyendra Kumar Also directs: Axial Pharmaceuticals Private Limited | Director | 11 Sep 2007 | 19 Years 1 Months | Current |
| Bibhuti Kumar Verma Also directs: Axial Pharmaceuticals Private Limited | Director | 11 Sep 2007 | 19 Years 1 Months | Current |
Auditor
Surge Pharmaceuticals Private Limited is audited by CHIRAG MODI & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHIRAG MODI & CO. | FY 2024 | 154068 |
Shareholding
The shareholding of Surge Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Surge Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2017 | 100123427 | Axis Bank Limited | ₹4.7 Cr | Open | |
| 18 Jul 2018 | 100207638 | Others | ₹2.25 Cr | Satisfied |
To see the full charge records of Surge Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Surge Pharmaceuticals Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2020.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Rights issue | ₹60 Lakh | Investors: 2 individuals |
| Mar 2017 | Rights issue | ₹49 Lakh | Investors: 2 individuals |
| Oct 2009 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Surge Pharmaceuticals Private Limited has 17 court cases on record: 4 filed by Surge Pharmaceuticals, 13 filed against it. 5 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 12 | 5 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Court case (TMSUIT) | Filed against the company by Surge Biotech Pvt. Ltd. | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by B2b Hospitality Pvt. Ltd. | Disposed |
| High Court, GUJARAT | Court case (AO) | Filed against the company by Surge Biotech Pvt Ltd | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Solan, Himachal Pradesh | Civil suit | Filed against the company by an individual | Pending |
To see the full case history of Surge Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surge Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Surge Pharmaceuticals Private Limited has a workforce of 18 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Surge Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AALCS4016J1ZL | Bihar | Active | 01 Jul 2017 |
| 27AALCS4016J1Z6 | Maharashtra | Active | 24 Dec 2017 |
To see the full GST registrations and return filing status of Surge Pharmaceuticals Private Limited, buy the company report.
Recent activity
Surge Pharmaceuticals Private Limited has 5 board changes on record since 2007: 2 appointments and 3 cessations. The latest: Prem Sagar ceased to be Director on 16 Oct 2009.
Frequently asked questions
Surge Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 September 2007 (19+ years old) and is registered under CIN U24239GJ2007PTC051709.
Surge Pharmaceuticals has 2 current directors:
- Satyendra Kumar - Director
- Bibhuti Kumar Verma - Director
The latest financial statements of Surge Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Surge Pharmaceuticals is 10AALCS4016J1ZL, registered in Bihar. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 27AALCS4016J1Z6 (Maharashtra).
The CIN (Corporate Identification Number) of Surge Pharmaceuticals is U24239GJ2007PTC051709. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surge Pharmaceuticals has 17 court cases on record: 4 filed by the company and 13 filed against it. 5 are pending. Most are in the district courts.
Surge Pharmaceuticals was incorporated on 11 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Surge Pharmaceuticals has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2020.
Prem Sagar ceased to be Director on 16 Oct 2009. Suman Kumar Chaudhary ceased to be Director on 16 Oct 2009. Vindhya Prakash ceased to be Director on 16 Oct 2009. Surge Pharmaceuticals has 5 board changes on record in total.
Surge Pharmaceuticals can be reached through the website surgepharma.com. Its registered office is in Vadodara, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
